Cordis, Abbott Continue Battle Over Stent Patents

Law360, New York (June 13, 2007, 12:00 AM EDT) -- Johnson & Johnson subsidiary Cordis Corp. has struck the most recent blow in its battle with Abbott Laboratories over the $2 billion annual U.S. market for drug-eluting coronary stents, filing a infringement suit against Abbott based on a patent that was issued Tuesday.

Cordis Corp. filed the lawsuit on Monday, in federal court in New Jersey, naming Abbott as the sole defendant. Tuesday, Abbott asked a Delaware court for permission to add Cordis' new patent to a declaratory judgment suit Abbott filed in 2006.

Cordis and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.